Personalised Medicine News
Researchers at UCL and Queen’s University Belfast have discovered that a drug originally developed to treat cardiovascular disease has the potential to reduce diabetes related blindness.
Published: Jun 14, 2016 1:02:15 PM
Drugs currently being trialled in cancer patients have been used to successfully target an autoimmune condition in mice at UCL and King’s College London.
Published: Jun 10, 2016 4:18:28 PM
Safer precision radiotherapies that will be able to cure more cancers with fewer side-effects will be available within five years under ambitious new plans for research and treatment at the UCL Cancer Institute and University College London Hospitals (UCLH) NHS Foundation Trust.
Published: Apr 22, 2016 9:36:29 AM
Universities and Science Minister Jo Johnson has sought to reassure researchers that the proposed restrictions preventing the use of government grants to ‘lobby’ government will not apply to funding from the Research Councils, HEFCE or the National Academies.
Published: Apr 21, 2016 10:20:47 AM
A drug currently being trialled in cancer patients could also be used to treat an often incurable condition that can cause painful blood vessel overgrowths inside the skin, finds new research in mice led by UCL, Memorial Sloan Kettering (MSK) Cancer Center in New York and the Bellvitge Biomedical Research Institute (IDIBELL) in Barcelona.
Published: Mar 31, 2016 12:48:52 PM
A new drug to treat the muscle wasting disease inclusion body myositis (IBM) reverses key symptoms in mice and is safe and well-tolerated in patients, finds a new study led by the Medical Research Council (MRC) Centre for Neuromuscular Diseases at UCL and the University of Kansas Medical Center.
Published: Mar 24, 2016 9:19:13 AM
The reason why the body’s immune cells cause so much damage and can’t regulate themselves in patients with lupus has been revealed in a UCL study published in the journal Immunity, a finding which could lead to more effective ways of treating lupus.
Published: Mar 9, 2016 5:15:35 PM
Scientists at UCL have made a groundbreaking discovery in understanding how the genetic complexity of tumours can be recognised and exploited by the immune system, even when the disease is at its most advanced stages.
Published: Mar 4, 2016 9:35:45 AM
A group of drugs being developed to treat mood disorders could also relieve chronic pain, finds new UCL research funded by the Medical Research Council.
Published: Feb 11, 2016 9:20:19 AM
HIV drug resistance to tenofovir, an antiretroviral drug vital to most
modern HIV treatment and prevention strategies, is surprisingly and worryingly common
according to a large study led by UCL and funded by the Wellcome Trust.
Published: Jan 29, 2016 10:02:47 AM
Two papers from UCL show that having early chemotherapy improves survival for men with prostate cancer. The papers, published in the Lancet and Lancet Oncology, report the results from the STAMPEDE clinical trial and a meta-analysis.
Published: Dec 22, 2015 9:17:00 AM
New results from the world’s biggest ovarian cancer screening trial led by UCL suggest that screening based on an annual blood test may help reduce the number of women dying from the disease by around 20%.
Published: Dec 17, 2015 11:59:43 AM
A potential new approach to treat systemic amyloidosis, invented at UCL and being developed by GlaxoSmithKline (GSK), marks the start of a successful and innovative academic-industry collaboration.
Published: Jul 16, 2015 11:57:29 AM
UCL has successfully coordinated a £16 million bid to work with the Medical Research Council (MRC), GSK and four other universities to improve scientists’ understanding of inflammatory and fibrotic diseases that present a serious burden to patients.
Published: Jul 15, 2015 10:25:45 AM
A landmark study that has been following a group of people since their birth in the same week in March 1946 is now turning its focus to the risk factors and early signs of dementia.
Published: Jul 14, 2015 10:05:31 AM